Orthofix Medical Inc. (OFIX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 300M 600M 900M FY09: 545.6M FY10: 462.6M FY11: 435.5M FY12: 440.2M FY13: 397.6M FY14: 402.3M FY15: 396.5M FY16: 409.8M FY17: 433.8M FY18: 453M FY19: 460M FY20: 406.6M FY21: 464.5M FY22: 460.7M FY23: 746.6M FY24: 799.5M FY25: 822.3M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 200M 400M 600M FY09: 407.2M FY10: 365.5M FY11: 339.1M FY12: 339.5M FY13: 290.7M FY14: 303.4M FY15: 310M FY16: 321.9M FY17: 340.8M FY18: 356.4M FY19: 359.3M FY20: 304.7M FY21: 349.6M FY22: 337.2M FY23: 486.3M FY24: 545.9M FY25: 566M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

-150M -100M -50M 0 50M 100M 150M FY09: 63.9M FY10: 66M FY11: 6.6M FY12: 74.9M FY13: -11.2M FY14: 17.1M FY15: 9.3M FY16: 21.1M FY17: 40.8M FY18: 30.1M FY19: -18.8M FY20: -6.3M FY21: -8.3M FY22: -13.3M FY23: -139.1M FY24: -84.6M FY25: -81.4M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-180M -120M -60M 0 60M 120M 180M FY09: 24.5M FY10: 44.3M FY11: -17.7M FY12: 42.9M FY13: -28.8M FY14: -8.5M FY15: -2.8M FY16: 3.1M FY17: 6.2M FY18: 13.8M FY19: -28.5M FY20: 2.5M FY21: -38.4M FY22: -19.7M FY23: -151.4M FY24: -126M FY25: -92.2M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 90M 180M 270M FY09: 138.4M FY10: 97.1M FY11: 96.4M FY12: 100.7M FY13: 106.9M FY14: 98.9M FY15: 86.5M FY16: 87.9M FY17: 93M FY18: 96.6M FY19: 100.6M FY20: 101.9M FY21: 114.9M FY22: 123.5M FY23: 260.4M FY24: 253.6M FY25: 256.3M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

-60M -30M 0 30M 60M 90M FY09: 50.6M FY10: 42.3M FY11: 64.7M FY12: 10.2M FY13: 67M FY14: 51.2M FY15: 43.6M FY16: 59.1M FY17: 39M FY18: 49.9M FY19: 32M FY20: 74.3M FY21: 18.5M FY22: -11.5M FY23: -45.8M FY24: 25.8M FY25: 33.3M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-120M -80M -40M 0 40M 80M 120M FY09: 29.7M FY10: 16.5M FY11: 39.8M FY12: -17.8M FY13: 42.3M FY14: 33.1M FY15: 16.4M FY16: 42.6M FY17: 24.3M FY18: 36.3M FY19: 13M FY20: 58.8M FY21: 690K FY22: -32.9M FY23: -106M FY24: -9.1M FY25: -1.3M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 15M 30M 45M FY09: 17.2M FY10: 17.9M FY11: 18.2M FY12: 19.4M FY13: 18.7M FY14: 18.5M FY15: 18.8M FY16: 18.5M FY17: 18.5M FY18: 18.9M FY19: 18.9M FY20: 19.4M FY21: 19.7M FY22: 20.1M FY23: 36.7M FY24: 38.1M FY25: 39.6M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q4 '10: 2.48 Q1 '11: -0.51 Q2 '11: -0.54 Q3 '11: -0.36 Q4 '11: -0.38 Q1 '12: 2.11 Q2 '12: 1.94 Q3 '12: 1.53 Q4 '12: 2.28 Q1 '13: 1.97 Q2 '13: 1.44 Q3 '13: 0.15 Q4 '13: -1.60 Q1 '14: -1.92 Q2 '14: -1.80 Q3 '14: -0.74 Q4 '14: -0.47 Q1 '15: -0.78 Q2 '15: -0.55 Q3 '15: -0.64 Q4 '15: -0.15 Q1 '16: 0.50 Q2 '16: -0.10 Q3 '16: 0.51 Q4 '16: 0.15 Q1 '17: -0.20 Q2 '17: 0.42 Q3 '17: 0.07 Q4 '17: 0.33 Q1 '18: 0.75 Q2 '18: 0.59 Q3 '18: 0.33 Q4 '18: 0.71 Q1 '19: 0.49 Q2 '19: 0.41 Q3 '19: -1.66 Q4 '19: -1.52 Q1 '20: -0.25 Q2 '20: -1.18 Q3 '20: 1.20 Q4 '20: 0.13 Q1 '21: -1.49 Q2 '24: -3.19 Q3 '24: -3.13 Q4 '24: -3.29 Q1 '25: -3.69 Q2 '25: -3.17 Q3 '25: -3.03 Q4 '25: -2.33 Q1 '26: -1.50 Q2 '26: -1.53 Q1 '11 Q4 '12 Q3 '14 Q2 '16 Q1 '18 Q4 '19 Q3 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.